The latest generation of Medicovid-AG SARS-CoV-2 Antigen Self-Test, capable of qualitative detection of the specific SARS-CoV-2 antigen through human nasal swabs, is now approved for self-testing.
Right at the start of the new season for the German Ice Hockey League (DEL), which opens on 17 December 2020 with the local derby between the Cologne Sharks and the Düsseldorf EG, MEDICE, with MediGel, is the new official partner of the DEL.
The specialist herbal treatment for dry irritating coughs.
Since 1 November 2020, the skin product portfolio of MEDICE has grown to include the innovative medical skincare product AktivaDerm® ND, a skincare treatment with active probiotics for neurodermatitis.
Medicovid SARS-CoV-2 IgG/IgM rapid test is an EU-licensed, CE-certified in-vitro diagnostic rapid test for the qualitative and semi-quantitative detection of IgM and IgG antibodies against the SARS-CoV-2 coronavirus in human serum or whole blood (obtained via venipuncture). The test combines immunoassay and chromatography and produces a result from venous whole blood within 15 minutes at the point of care with a proven high degree of sensitivity to IgM and IgG of 96.2% and a high level of specificity of 97.9% with the test remaining unresponsive to antibodies of other coronaviruses (HKU1, OC43, NL63, 229E) or chlamydia and mycoplasmas.
Modern office premises in the heart of Cologne give MEDICE employees the opportunity to work near their homes.
In-house honey - since the spring, this has been provided by three bee colonies which have taken up residence on the MEDICE company site.
The Pütter family at Medice focus on innovative quality products, with the employee taking centre place.
Helge Braun, Head of the Federal Chancellor's Office, stopped off in Iserlohn on Thursday, 14.08.2020 and visited pharma corporation MEDICE and the Iserlohn local newspaper IKZ.
Pharmaceutical producer from Westphalia takes aim at the Russian market.
Meditonsin is THE OTC preparation with the highest customer recommendation rating in Germany.
One of the main challenges for 2020 was launching Medikinet Retard in Costa Rica. The official launch event was scheduled and organized for March 2020, when COVID-19 was classified as a global pandemic.
Two new international MEDICE-subsidiaries in Norway and Denmark
NEW within the MEDICE-portfolio: Alflorex® against irritable colon syndrome!
Medikinet retard secures a registration expansion in 11 more European countries for the treatment of ADHD in adults